載入...
Therapeutic benefit of apremilast on enthesitis and dactylitis in patients with psoriatic arthritis: a pooled analysis of the PALACE 1–3 studies
OBJECTIVE: The Psoriatic Arthritis Long-term Assessment of Clinical Efficacy (PALACE) clinical trial programme findings demonstrated that apremilast, an oral phosphodiesterase 4 inhibitor, is effective for treating psoriatic arthritis (PsA). Enthesitis and dactylitis are difficult-to-treat features...
Na minha lista:
| 發表在: | RMD Open |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BMJ Publishing Group
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6045740/ https://ncbi.nlm.nih.gov/pubmed/30018799 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/rmdopen-2018-000669 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|